Santhera Pharmaceuticals Holding AG
Develops innovative medicines for rare neuromuscular and mitochondrial disorders.
SANN | SW
Overview
Corporate Details
- ISIN(s):
- CH1276028821
- LEI:
- 54930035HAOFTTQH0U85
- Country:
- Switzerland
- Address:
- HOHENRAINSTRASSE 24, 4133 PRATTELN
- Website:
- https://www.santhera.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of innovative medicines for patients with rare diseases. The company targets conditions with high unmet medical needs, primarily in the area of rare neuromuscular and mitochondrial disorders. Santhera's mission is to provide treatment options for diseases that severely impact the lives of affected children and adults and currently have limited or no available therapies. Its development efforts include advanced treatments such as gene therapy for conditions like LAMA2-deficient congenital muscular dystrophy (CMD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Santhera Pharmaceuticals Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Santhera Pharmaceuticals Holding AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Santhera Pharmaceuticals Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-01-11 | N/A | Non-Executive member | Buy | None | 42,600.00 CHF |
| 2022-01-10 | N/A | Executive member | Buy | None | 14,420.00 CHF |
| 2022-01-05 | N/A | Executive member | Buy | None | 37,000.00 CHF |
Peer Companies
